Literature DB >> 9879743

Angiotensin II signal transduction pathways.

P P Sayeski1, M S Ali, D J Semeniuk, T N Doan, K E Bernstein.   

Abstract

It has been 100 years since the discovery of renin by Tigerstedt and Bergman. Since that time, numerous discoveries have advanced our understanding of the renin-angiotensin system, including the observation that angiotensin II is the effector molecule of this system. A remarkable aspect of angiotensin II is the many different physiological responses this simple peptide induces in different cell types. Here, we focus on the signal transduction pathways that are activated as a consequence of angiotensin II binding to the AT1 receptor. Classical signaling pathways such as the activation of heterotrimeric G proteins by the AT1 receptor are discussed. In addition, recent work examining the role of tyrosine phosphorylation in angiotensin II-mediated signal transduction is also examined. Understanding how these distinct signaling pathways transduce signals from the cell surface will advance our understanding of how such a simple molecule elicits such a wide variety of specific cellular responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879743     DOI: 10.1016/s0167-0115(98)00137-2

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

1.  The role of Ca2+ mobilization and heterotrimeric G protein activation in mediating tyrosine phosphorylation signaling patterns in vascular smooth muscle cells.

Authors:  P P Sayeski; M S Ali; K E Bernstein
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: response to angiotensin II AT1 receptor blockade.

Authors:  Sophie C Lütken; Soo Wan Kim; Thomas Jonassen; David Marples; Mark A Knepper; Tae-Hwan Kwon; Jørgen Frøkiaer; Søren Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

Review 3.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

4.  The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling.

Authors:  Marco Lopez-Ilasaca; Xiushi Liu; Koichi Tamura; Victor J Dzau
Journal:  Mol Biol Cell       Date:  2003-09-05       Impact factor: 4.138

5.  Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension.

Authors:  John W Wright; Shigehiko Mizutani; Joseph W Harding
Journal:  Int J Hypertens       Date:  2012-06-26       Impact factor: 2.420

Review 6.  New insights into the importance of aminopeptidase A in hypertension.

Authors:  Shigehiko Mizutani; Masakazu Ishii; Akira Hattori; Seiji Nomura; Yasushi Numaguchi; Masafumi Tsujimoto; Hiroshi Kobayshi; Toyoaki Murohara; John W Wright
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.